Latest Press Releases

Health News Posted on Tuesday, November 21, 2017

Press Releases »

Takeda's Entyvio Defends Share Against Janssen's Stelara in the Crohn's Disease Market, and Pressure in the Ulcerative Colitis Market May Heat Up in Early 2018 if Pfizer's Xeljanz Secures an FDA Win

According to a new report by Spherix Global Insights, Janssen's Remicade is taking a dual hit from the expansion of alternative mechanism of action biologics such as Entyvio and Stelara as well as the slow, but growing, adoption of infliximab biosimilars in the IBD market ...

Read More ...

AARP Illinois Urges Gov. Rauner To Sign Senior Care Protection Bill

Bill safeguards critical senior in-home and community care for over 80,000 Illinoisans SPRINGFIELD, Ill. , Nov. 21, 2017 /PRNewswire-USNewswire/ -- "House Bill 1424, sponsored by State Representative Greg Harris and Senator Daniel Biss , is a compassionate, fiscally responsible measure th...

Read More ...

SCRS Welcomes New Global Impact Partner, CPi Global CRO

ELLICOTT CITY, Md. , Nov. 21, 2017 /PRNewswire/ -- The Society for Clinical Research Sites (SCRS) announced today that CPi Global CRO has joined the organization as a Global Impact Partner (GIP). SCRS' GIP Program provides a unique opportunity for sponsors, CROs and vendors to engage with SCRS ...

Read More ...

Statement by the Honourable Jane Philpott in response to the 2017 Fall Report of the Auditor General of Canada

OTTAWA , Nov. 21, 2017 /CNW/ - Following the tabling of the 2017 Fall Report of the Auditor General of Canada , the Honourable Jane Philpott, Minister of Indigenous Services issued the following statement: "Our Government is committed to a renewed relationship with Indigenous peoples based on...

Read More ...

People in Four States May Be Drinking Contaminated Raw Milk

CDC and partners urge families at risk to see their doctor for antibiotics ...

Read More ...

Recent Chart Audit Reveals Switching Rheumatoid Arthritis Patients to Roche/Genentech's RoActemra (Actemra) is Significantly More Common in the EU5 than it is in the US

EU5 adoption of Pfizer's Xeljanz and Eli Lilly's Olumiant has been largely limited to rheumatologists practicing in Germany, according to a recently released independent report by Spherix Global Insights ...

Read More ...

Baptist Health joins CareSource Health Plan Network

CareSource Marketplace members have access to the largest nonprofit health system in Kentucky ...

Read More ...

Neurocrine Biosciences to Present at the 29th Annual Piper Jaffray Healthcare Conference

Live Audio Webcast Will be on November 28, 2017 SAN DIEGO , Nov. 21, 2017 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NASDAQ: NBIX) will present at the 29th Annual Piper Jaffray Healthcare Conference at 12:00 p.m. ET on Tuesday, Nov. 28, 2017 , in New York City . Timothy P. Coug...

Read More ...

Broward Health Announces Pricing and Sale of $317 Million of Tax-Exempt Bonds

FORT LAUDERDALE, Fla. , Nov. 21, 2017 /PRNewswire/ -- Broward Health this morning announced the successful pricing and sale of $317 million of tax-exempt Revenue Bonds, Series 2017B (the "Bonds").  The Bonds were fully subscribed within five hours of being made available yesterday to retail a...

Read More ...

Early Adopters in Germany and the United Kingdom Are Prescribing Merck KGaA's Mavenclad as First-Line Induction Therapy for the Treatment of Multiple Sclerosis

European neurologists predict substantial uptake of Roche's Ocrevus among primary progressive multiple sclerosis patients driven by favorable market access status and an absence of on-label competition, according to a new EU5 report from Spherix Global Insights ...

Read More ...

Janssen Submits Application to U.S. FDA to Expand Indication for DARZALEX® (daratumumab) Combination Therapy for Patients with Newly Diagnosed Multiple Myeloma who are Transplant Ineligible

Supplemental Biologics License Application (sBLA) seeks first indication for DARZALEX for the treatment of newly diagnosed patients RARITAN, N.J. , Nov. 21, 2017 /PRNewswire/ -- Janssen Biotech, Inc. today announced that it has submitted a supplemental Biologics License Application (sBLA) to...

Read More ...

MiMedx to Present at the 29th Annual Piper Jaffray Healthcare Conference

MARIETTA, Ga. , Nov. 21, 2017 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), the leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics utilizing human placental tissue allografts and patent-protected processes for multiple sectors of healthcare, a...

Read More ...

Glassbeam Announces Healthcare Industry's First Industrial IoT Analytics Blueprint

Blueprint in production at leading sites such as Novant Health ...

Read More ...

Novus Detox Center Alerts Police and EMS to Risk of Accidental Fentanyl Overdose

Recent reports document accidental fentanyl overdoses among police officers, and fentanyl/synthetic opioid overdose deaths have doubled in just one year. Novus Detox Center urges first responders to be aware of the danger and take precautions. NEW PORT RICHEY, Fla. , Nov. 21, 2017 /PRNewswir...

Read More ...

Climbing Costs for Treating Breast Cancer Poised to Strain Medicare in the Near Future

New study in JNCCN calls for more planning and research to prepare for the increasing financial burden of treating breast cancer. ...

Read More ...

The Len Cerullo Method Clinic Opens the Doors to its First Location

Led by founder and recognized neurosurgeon Len Cerullo, M.D., the care team is dedicated to alleviating pain with surgery as the last option ...

Read More ...

Avelas Biosciences to Present at Piper Jaffray Healthcare Conference

SAN DIEGO , Nov. 21, 2017 /PRNewswire/ -- Avelas Biosciences, Inc., a clinical stage oncology-focused company dedicated to improving cancer patient care from diagnosis through treatment, today announced that Carmine N. Stengone , president and chief executive officer, will present at the 29 th...

Read More ...

Le-Vel Unveils Thrive Experience 2.0

Next generation of products builds on global success ...

Read More ...

AMCP Partnership Forum Identifies Key Opportunities to Improve Patient Financial Burden in Oncology and Shift to Value-Based Care Models

Greater Cost Transparency and Focus on Patient Needs and Experience Were Among Takeaways at Two-Day Meeting ...

Read More ...

KUBO Group Engaged to Construct Advanced World Class Cannabis Production Facility in New South Wales, Australia

VANCOUVER, British Columbia , November 21, 2017 /PRNewswire/ -- MYM Nutraceuticals Inc. (CSE:MYM)(CSE: MYM.CN)(MYM.CN)(OTC:MYMMF) (the "Company" or "MYM") is pleased to announce that Puf Ventures Australia (the "Company") has engaged renowned Dutch greenhouse builder, KUBO for, engineering and...

Read More ...

New Stax™ mAx Clarification Platform from Pall Life Sciences Delivers Robust, Accelerated Performance Across Multiple mAb Processes

PORT WASHINGTON, N.Y. , Nov. 21, 2017 /PRNewswire/ -- Pall Corporation, a global leader in filtration, separation and purification, is formally introducing the Stax mAx clarification platform, a robust solution for the economic clarification of monoclonal antibody cell cultures without centrifu...

Read More ...
More Press Releases

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store